These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18311490)

  • 21. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
    Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
    G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis.
    Abdul-Wahab A; Tang SY; Robson A; Morris S; Agar N; Wain EM; Child F; Scarisbrick J; Neat M; Whittaker S
    J Am Acad Dermatol; 2014 Jun; 70(6):1010-20. PubMed ID: 24679486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
    Felcht M; Booken N; Stroebel P; Goerdt S; Klemke CD
    J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous B-cell lymphoma: important diagnostic tools.
    Ferenczi K
    G Ital Dermatol Venereol; 2010 Jun; 145(3):361-73. PubMed ID: 20461044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
    Kempf W; Kazakov DV; Mitteldorf C
    Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
    Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
    Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Aggressive Primary Cutaneous Follicle Center Lymphoma With c-MYC Translocation and CDKN2A (9p21) Deletion: A Case Report and Review of the Literature.
    Tsang HC; Mathew S; Magro CM
    Am J Dermatopathol; 2017 Mar; 39(3):e44-e49. PubMed ID: 27759694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary cutaneous follicle center lymphoma in a 16-year-old girl.
    Edmonds N; Hernández-Pérez M; Holsinger M; Gru AA
    J Cutan Pathol; 2021 May; 48(5):663-668. PubMed ID: 33326136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.
    Brown VL; Harwood CA; Crook T; Cronin JG; Kelsell DP; Proby CM
    J Invest Dermatol; 2004 May; 122(5):1284-92. PubMed ID: 15140233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
    Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
    Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.
    Hoefnagel JJ; Dijkman R; Basso K; Jansen PM; Hallermann C; Willemze R; Tensen CP; Vermeer MH
    Blood; 2005 May; 105(9):3671-8. PubMed ID: 15308563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ; Willemze R
    Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma.
    Child FJ; Russell-Jones R; Woolford AJ; Calonje E; Photiou A; Orchard G; Whittaker SJ
    Br J Dermatol; 2001 Apr; 144(4):735-44. PubMed ID: 11298531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal imbalances: a hallmark of tumour relapse in primary cutaneous CD30+ T-cell lymphoma.
    Prochazkova M; Chevret E; Beylot-Barry M; Sobotka J; Vergier B; Delaunay M; Turmo M; Ferrer J; Kuglik P; Merlio JP
    J Pathol; 2003 Nov; 201(3):421-9. PubMed ID: 14595754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
    Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
    Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma.
    Pham-Ledard A; Prochazkova-Carlotti M; Andrique L; Cappellen D; Vergier B; Martinez F; Grange F; Petrella T; Beylot-Barry M; Merlio JP
    Mod Pathol; 2014 Mar; 27(3):402-11. PubMed ID: 24030746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.